504 Participants Needed

Depression Screening for Depression

Recruiting at 2 trial locations
SH
Overseen BySidney Hankerson, MD, MBA
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial uses Community Health Workers to screen for depression in Black churches and aims to improve treatment engagement and mental health outcomes among African American adults, who are less likely to be screened for depression in primary care settings. By using trusted community members, the study aims to encourage more people to seek treatment after screening positive for depression.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

Is the SBIRT process safe for humans?

SBIRT (Screening, Brief Intervention, and Referral to Treatment) is generally considered safe as it is an evidence-based practice used to identify and help people with substance use and mental health issues, including depression. It is implemented in various healthcare settings to provide early intervention and support, with no specific safety concerns reported in the research articles.12345

How does the SBIRT treatment for depression differ from other treatments?

SBIRT (Screening, Brief Intervention, and Referral to Treatment) is unique because it focuses on early identification and intervention through screening and brief counseling, followed by referral to specialized care if needed. Unlike traditional treatments that may start with medication or therapy, SBIRT emphasizes initial screening and brief intervention to address depression early, potentially improving follow-up and treatment adherence.678910

What data supports the effectiveness of the treatment Referral as Usual, Referral as Usual, Standard Referral Process, SBIRT, Screening, Brief Intervention, and Referral to Treatment for depression?

Research shows that SBIRT (Screening, Brief Intervention, and Referral to Treatment) is an effective method for identifying and addressing substance use issues, and it is recommended for use in primary care settings to help manage mental health and substance abuse concerns.111121314

Who Is on the Research Team?

OW

Olajide Williams, MD, MS

Principal Investigator

Columbia University

Are You a Good Fit for This Trial?

This trial is for English-speaking adults over 18 in Black church communities who may be experiencing depression, as indicated by specific questionnaire scores. It's not open to those already in formal mental health treatment or individuals with active suicidal thoughts, homicidal ideation, or psychotic symptoms.

Inclusion Criteria

Fluent in English
You have a score of 10 or higher on the Patient Health Questionnaire-9.
You have a high score (10 or more) on two questionnaires that measure symptoms of depression and anxiety.

Exclusion Criteria

I am currently in treatment for a mental health condition.
I have not had thoughts of harming myself or others, nor experienced severe mental health symptoms.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks
1 visit (in-person)

Intervention

Participants receive either SBIRT or Referral As Usual intervention

3-6 months
Multiple visits (in-person and virtual)

Follow-up

Participants are monitored for changes in mental health-related quality of life and depressive symptoms

6 months
2 visits (in-person or virtual)

What Are the Treatments Tested in This Trial?

Interventions

  • Referral as Usual
  • SBIRT
Trial Overview The study compares two approaches: usual referral methods versus a more involved process called SBIRT (Screening, Brief Intervention, and Referral to Treatment) conducted by Community Health Workers. The effectiveness on engaging patients with depression treatments will be measured.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: SBIRTExperimental Treatment1 Intervention
Group II: Referral As UsualActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Columbia University

Lead Sponsor

Trials
1,529
Recruited
2,832,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Published Research Related to This Trial

The study analyzed prescreening outcomes from 14,447 patient visits in both inpatient and outpatient settings, finding that both the medical setting and the method of prescreening (self-administered vs interview) significantly influenced the results.
Among patients who prescreened positive for alcohol, the setting also affected their mean screening scores, indicating that the effectiveness of SBIRT may vary based on the context and method of administration.
An Assessment of SBIRT Prescreening and Screening Outcomes by Medical Setting and Administration Methodology.Agley, J., Crabb, DW., Harris, LE., et al.[2020]
A study involving 361 undergraduate student nurses showed that SBIRT training significantly increased their knowledge, confidence, and perceived competence in addressing substance use disorders, with 89% reporting improved skills.
The majority of students (93%) expressed intent to apply their SBIRT skills in future practice, highlighting the importance of integrating this training into nursing education to enhance substance use screening in clinical settings.
Student Nurse Screening, Brief Intervention and Referral to Treatment Training Program: Analysis 2016-2019.Zucker, DM., Rataj, S., Linowski, S., et al.[2023]
The study identified seven distinct SBIRT processes for substance use and five for tobacco use across 14 acute care facilities, highlighting variability in implementation despite a consistent overall function.
To effectively disseminate SBIRT in acute care settings, it is crucial to understand and tailor the implementation strategies to the specific local contexts and clinician involvement at each facility.
Variation in SBIRT delivery among acute care facilities.Keen, A., Thoele, K., Newhouse, R.[2020]

Citations

An Assessment of SBIRT Prescreening and Screening Outcomes by Medical Setting and Administration Methodology. [2020]
Student Nurse Screening, Brief Intervention and Referral to Treatment Training Program: Analysis 2016-2019. [2023]
Variation in SBIRT delivery among acute care facilities. [2020]
A Phone Consultation Call Line to Support SBIRT in Pediatric Primary Care. [2022]
Workflow Improvement and the Use of PDSA Cycles: An Exploration Using Screening, Brief Intervention, and Referral to Treatment (SBIRT) Integration. [2021]
Student Experience of School Screening, Brief Intervention, and Referral to Treatment. [2021]
Implementing SBIRT (Screening, Brief Intervention and Referral to Treatment) in primary care: lessons learned from a multi-practice evaluation portfolio. [2022]
Study protocol testing toolkit versus usual care for implementation of screening, brief intervention, referral to treatment in hospitals: a phased cluster randomized approach. [2020]
Screening, brief intervention, and referral to treatment (SBIRT) implementation in urban underserved family medicine. [2023]
10.United Statespubmed.ncbi.nlm.nih.gov
Depression screening as a quality indicator. [2021]
Not Missing the Opportunity: Improving Depression Screening and Follow-Up in a Multicultural Community. [2020]
The depression puzzle. Do the pieces fit? [2006]
Validity of brief screening questionnaires to detect depression in primary care in Ethiopia. [2022]
14.United Statespubmed.ncbi.nlm.nih.gov
Major Depressive Disorder in Primary Care: Strategies for Identification. [2020]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security